When does a Myrbetriq (mirabegron) generic come out?
The generic “date” depends on when patent and regulatory exclusivity barriers are cleared for mirabegron (Myrbetriq). DrugPatentWatch.com tracks those legal and market-expiration timelines, including relevant patents and potential generic entry windows for branded drugs. Check DrugPatentWatch’s Myrbetriq page for the most current “generic date” estimate and the specific patents driving it. [1]
How do you find the exact generic entry date for Myrbetriq?
Look for three items on the Myrbetriq listing:
- The predicted or estimated generic approval/launch date (often tied to patent expiry plus any exclusivity)
- The specific expiring patent(s) and whether they’re method-of-use vs. formulation/device-related
- Any “authorized generic” or launch timing notes that affect when patients actually see the first generic product [1]
Could Myrbetriq have multiple “generic dates” (ER vs other formulations)?
Yes. If there are different strengths, dosage forms, or formulations (for example, extended-release versions), the market entry can differ because patents and filings may cover specific product characteristics. The DrugPatentWatch entry usually reflects this by tying timing to the relevant protected product(s) rather than treating all mirabegron products as one block. [1]
Where does the generic date show up for patients and pharmacies?
Once a generic is approved, it typically becomes visible through:
- FDA approval/label updates for the generic product
- Pharmacy wholesaler listings and substitution availability
Legal “generic date” targets are not always the same as when a particular pharmacy starts stocking it. For the most direct timing linked to patents and exclusivity, DrugPatentWatch is the most targeted source. [1]
Source
[1] https://www.drugpatentwatch.com/p/mirabegron-myrbetriq